Measures · C11 in 2024 · Part C · HD2 Managing Chronic (Long Term) Conditions
Controlling High Blood Pressure
Chronic ConditionsHealth PlanSource: HEDIS
- What it measures
- Percent of plan members with high blood pressure who got treatment and were able to maintain a healthy pressure.
- How it's calculated
- The percentage of MA members 18–85 years of age who had a diagnosis of hypertension (HTN) (denominator) and whose BP was adequately controlled (<140/90 mm Hg) (numerator).
- Data source
- HEDIS
- Measurement period
- 01/01/2022 – 12/31/2022
- Better when
- Higher
- Weight
- 3 (Intermediate Outcomes Measure)
- Star assignment
- Clustering
- Case-mix adjusted
- No
- In improvement measure
- Yes
- Used in CAI
- Yes
- HEDIS label
- Controlling High Blood Pressure (CBP)
- Exclusions
Show
Exclude members who meet any of the following criteria: • Members 66 years of age and older as of December 31 of the measurement year who meet either of the following: − Enrolled in an Institutional SNP (I-SNP) any time during the measurement year. − Living long-term in an institution any time during the measurement year as identified by the LTI flag in the Monthly Membership Detail Data File. Use the run date of the file to determine if a member had an LTI flag during the measurement year. • Members 81 years of age and older as of December 31 of the measurement year with frailty (Frailty Value Set) during the measurement year. • Members 66–80 years of age and older as of December 31 of the measurement year with frailty (Frailty Value Set) and advanced illness during the measurement year. • A dispensed dementia medication. • Members receiving palliative care (Palliative Care Assessment Value Set; Palliative Care Encounter Value Set; Palliative Care Intervention Value Set) during the measurement year. (Optional) • Exclude from the eligible population all members with evidence of end-stage renal disease (ESRD) (ESRD Value Set; ESRD Obsolete Value Set) or kidney transplant (Kidney Transplant Value Set) on or prior to December 31 of the measurement year. Documentation in the medical record must include a dated note indicating evidence of ESRD, kidney transplant or dialysis. • Exclude from the eligible population all members with a diagnosis of pregnancy (Pregnancy Value Set) during the measurement year. • Exclude from the eligible population all members who had a nonacute inpatient admission during the measurement year. To identify nonacute inpatient admissions: 1. Identify all acute and nonacute inpatient stays (Inpatient Stay Value Set). 2. Confirm the stay was for nonacute care based on the presence of a nonacute code (Nonacute Inpatient Stay Value Set) on the claim. 3. Identify the admission date for the stay. Contracts whose enrollment was at least 500 but less than 1,000 as of the July 2022 enrollment report and having measure score reliability less than 0.7 are excluded. Contracts whose enrollment was less than 500 as of the July 2022 enrollment report are excluded from this measure.- Disaster policy
- Higher measure star (2023-2024) for contracts with 25% or more enrolled affected by 2022 disasters.
From the 2024 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA | 72 | 77 | +5 |
| 3★ | MA | 79 | 83 | +4 |
| 4★ | MA | 84 | 85 | +1 |
| 5★ | MA | 90 | 92 | +2 |
2024 star distribution
Not rated: Plan too new to be measured (93); Plan too small to be measured (83); Plan not required to report measure (59); No data available (31); Not enough data available (26)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA | < 72 % | >= 72 % to < 79 % | >= 79 % to < 84 % | >= 84 % to < 90 % | >= 90 % |
| 2026 | MA | < 67 % | >= 67 % to < 75 % | >= 75 % to < 80 % | >= 80 % to < 86 % | >= 86 % |
| 2025 | MA | < 69 % | >= 69 % to < 74 % | >= 74 % to < 80 % | >= 80 % to < 85 % | >= 85 % |
| 2024 | MA | < 58 % | >= 58 % to < 68 % | >= 68 % to < 74 % | >= 74 % to < 82 % | >= 82 % |
| 2023 | MA | < 48 % | >= 48 % to < 63 % | >= 63 % to < 73 % | >= 73 % to < 80 % | >= 80 % |
| 2019 | MA | < 51% | ? 51% to < 62% | ? 62% to < 75% | ? 75% to < 82% | ? 82% |
| 2018 | MA | < 55% | ? 55% to < 67% | ? 67% to < 75% | ? 75% to < 86% | ? 86% |
| 2017 | MA | < 38% | ? 38% to < 56% | ? 56% to < 64% | ? 64% to < 75% | ? 75% |
| 2016 | MA | < 47% | ? 47% to < 62% | ? 62% to < 75% | ? 75% to < 82% | ? 82% |
| 2015 | MA | < 42% | ? 42% to < 53% | ? 53% to < 63% | ? 63% to < 75% | ? 75% |
Lowest-scoring contracts, 2024
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| H2162 Wellcare | Centene Corporation | 0 | 11 | 1 | — | 63 | 0% |
| H9976 Wellcare by Allwell | Centene Corporation | — | 23 | 1 | — | 51 | 0% |
| H1395 Wellcare | Centene Corporation | 2,553 | 29 | 1 | — | 45 | 0% |
| H3015 Shared Health Dual Plus - DE H3015-001 (HMO D-SNP) | BlueCross BlueShield of Tennessee | — | 31 | 1 | — | 43 | 1% |
| H7169 Wellcare By Allwell | Centene Corporation | — | 40 | 1 | — | 34 | 1% |
| H9387 Wellcare | Centene Corporation | 847 | 41 | 1 | — | 33 | 1% |
| H9335 Wellcare | Centene Corporation | — | 46 | 1 | — | 28 | 1% |
| H2722 Primewell Health Services | Louisiana Health Service & Indemnity Company | — | 48 | 1 | — | 26 | 1% |
| H9900 Wellcare | Centene Corporation | — | 49 | 1 | — | 25 | 1% |
| H8553 Wellcare | Centene Corporation | — | 51 | 1 | — | 23 | 2% |
| H0074 Wellcare | Centene Corporation | 1,451 | 51 | 1 | — | 23 | 2% |
| H7559 Molina Healthcare of Virginia | Molina Healthcare, Inc. | — | 52 | 1 | — | 22 | 2% |
| H2128 Wellcare by Allwell | Centene Corporation | — | 52 | 1 | — | 22 | 2% |
| H0969 Wellcare | Centene Corporation | — | 54 | 1 | −1 | 20 | 2% |
| H0111 Wellcare | Centene Corporation | 6,204 | 54 | 1 | −1 | 20 | 2% |
| H1722 Healthfirst Medicare Plan | Healthfirst, Inc. | 1,924 | 54 | 1 | — | 20 | 2% |
| H5965 Wellcare | Centene Corporation | 1,556 | 54 | 1 | — | 20 | 2% |
| H3047 Wellcare | Centene Corporation | — | 56 | 1 | −1 | 18 | 3% |
| H5628 Molina Healthcare of Utah & Idaho | Molina Healthcare, Inc. | 16,554 | 56 | 1 | −1 | 18 | 3% |
| H1848 Wellcare | Centene Corporation | — | 56 | 1 | −1 | 18 | 3% |
| H2765 Summit Health Plan, Inc. | Moda Partners, Inc. | — | 56 | 1 | −1 | 18 | 3% |
| H2171 Care N' Care Insurance Company | Texas Health Resources | — | 56 | 1 | −2 | 18 | 3% |
| H2224 Molina Healthcare of Massachusetts | Molina Healthcare, Inc. | 10,410 | 57 | 1 | −2 | 17 | 4% |
| H1799 Passport Advantage | Molina Healthcare, Inc. | 2,617 | 57 | 1 | — | 17 | 4% |
| H9428 Wellcare | Centene Corporation | — | 57 | 1 | −1 | 17 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | C14 | Controlling High Blood Pressure | 01/01/2025 – 12/31/2025 | 3 | HEDIS |
| 2026 | C14 | Controlling High Blood Pressure | 01/01/2024 – 12/31/2024 | 3 | HEDIS |
| 2025 | C11 | Controlling High Blood Pressure | 01/01/2023 – 12/31/2023 | 3 | HEDIS |
| 2024 | C11 | Controlling High Blood Pressure | 01/01/2022 – 12/31/2022 | 3 | HEDIS |
| 2023 | C12 | Controlling Blood Pressure | 01/01/2021 – 12/31/2021 | 1 | HEDIS |
| 2019 | C16 | Controlling Blood Pressure | 01/01/2017 – 12/31/2017 | 3 | HEDIS |
| 2018 | C16 | Controlling Blood Pressure | 01/01/2016 – 12/31/2016 | 3 | HEDIS |
| 2017 | C16 | Controlling Blood Pressure | 01/01/2015 - 12/31/2015 | 3 | HEDIS |
| 2016 | C16 | Controlling Blood Pressure | 01/01/2014 - 12/31/2014 | 3 | HEDIS |
| 2015 | C18 | Controlling Blood Pressure | 01/01/2013 - 12/31/2013 | 3 | HEDIS |